A Digital Game on Promoting Family Well-being
Launched by THE UNIVERSITY OF HONG KONG · Oct 1, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how digital games can help improve family well-being and promote healthy living. Researchers believe that using games and technology can be an effective way to encourage families to engage in healthier habits together. As part of this study, they will conduct an online survey to learn more about how families currently use games for health promotion, followed by a family-based trial that will involve participating in these games.
To be eligible for this trial, participants need to be Chinese-speaking and have a smartphone. If anyone is under 18, they will need permission from their parents. The trial is open to individuals of all ages, and everyone who meets the criteria is welcome to join. If you decide to participate, you can expect to play games designed to promote healthy living and connect with your family in a fun way. Currently, the trial is not yet recruiting participants, but it aims to gather valuable insights into how games can support families in leading healthier lives.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Chinese-speaking;
- • Parental consent for those under 18;
- • Able to understand and play the game;
- • Has a smartphone.
- Exclusion Criteria:
- • • Individuals who cannot meet the inclusion criteria.
About The University Of Hong Kong
The University of Hong Kong (HKU) is a leading research institution dedicated to advancing medical knowledge and improving healthcare outcomes through innovative clinical trials. With a commitment to excellence in research and education, HKU collaborates with various stakeholders, including healthcare providers and industry partners, to conduct rigorous and ethically sound clinical studies. The university's diverse expertise and state-of-the-art facilities enable it to explore a wide range of therapeutic areas, contributing to the global pursuit of scientific advancement and the development of novel treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hong Kong, , Hong Kong
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported